E Fund Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.6K | Sell |
10,259
-1,652
| -14% | -$15.2K | ﹤0.01% | 377 |
|
|
2025
Q1 | $102K | Buy |
+11,911
| New | +$102K | ﹤0.01% | 382 |
|
|
2024
Q3 | – | Sell |
-13,623
| Closed | -$57.5K | – | 355 |
|
|
2024
Q2 | $57.5K | Sell |
13,623
-18,036
| -57% | -$76.1K | ﹤0.01% | 315 |
|
|
2024
Q1 | $161K | Buy |
31,659
+19,271
| +156% | +$98.1K | 0.01% | 358 |
|
|
2023
Q4 | $115K | Sell |
12,388
-1,520
| -11% | -$14.2K | 0.01% | 300 |
|
|
2023
Q3 | $91K | Sell |
13,908
-4,945
| -26% | -$32.4K | 0.01% | 286 |
|
|
2023
Q2 | $153K | Sell |
18,853
-7,561
| -29% | -$61.4K | 0.01% | 289 |
|
|
2023
Q1 | $226K | Buy |
26,414
+2,052
| +8% | +$17.6K | 0.02% | 275 |
|
|
2022
Q4 | $226K | Buy |
24,362
+5,547
| +29% | +$51.5K | 0.02% | 280 |
|
|
2022
Q3 | $194K | Sell |
18,815
-429
| -2% | -$4.42K | 0.02% | 309 |
|
|
2022
Q2 | $193K | Buy |
19,244
+777
| +4% | +$7.79K | 0.02% | 303 |
|
|
2022
Q1 | $227K | Buy |
+18,467
| New | +$227K | 0.01% | 272 |
|